Clinical Trial

ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 15, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Severe radiation dermatitis remains a challenging complication in head and neck cancer with limited treatment options; this study aims to evaluate a novel Prussian blue-based nanozyme combined with near-infrared thermotherapy to promote effective healing of Grade III lesions.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-24; most recent amendment 2026-04-14.
Trial Details
NCT Number NCT07086638
Lead Sponsor West China Hospital
Conditions Radiation Dermatitis
Enrollment 5 participants
Start Date 2025-07-25
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-10-25 (estimated)
Updated on ClinicalTrials.gov 2026-04-15